SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mangalam Drugs gearing up production of HCQS, CQP APIs

24 Mar 2020 Evaluate

Mangalam Drugs and Organics is gearing up production of Hydroxrychloroquine Sulphate (HCQS) and Chloroquine Phosphate (CQP) APIs to meet the demand in case these APIs are approved for treatment of patients affected by Coronavirus Disease (COVID-19) by regulatory authorities and safeguard lives of affected in these challenging times.

Mangalam Drugs and Organics manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base. 

Mangalam Drugs&Org. Share Price

29.75 0.02 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×